Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. (NeutroCure)
Third Party Funds Group - Sub project
Acronym: NeutroCure
Start date : 01.01.2020
End date : 31.12.2024
Danylo Halytsky Lviv National Medical University / Львiвський Національний Медичний Унiверситет iм. Данила Галицького
Ukraine (UA)
Institut Gustave-Roussy
France (FR)
Redoxis AB
Sweden (SE)
Spanish National Center for Cardiovascular Research / Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)
Spain (ES)
University of Surrey
United Kingdom (GB)
Ukraine (UA)
Institut Gustave-Roussy
France (FR)
Redoxis AB
Sweden (SE)
Spanish National Center for Cardiovascular Research / Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)
Spain (ES)
University of Surrey
United Kingdom (GB)